NewGenIvf NIVF
NASDAQ NIVF
$0.16 +0.09 (+127.45%)
As of: Sep 30, 2026 · 3:59 PM EDT

NewGenIvf (NIVF) EBIT Margin (2024 - 2025)

Updated

NewGenIvf (NIVF) recorded EBIT Margin of -349.13% in the quarter ended Dec 31, 2025, down 263.62 percentage points from -85.51% a year earlier and down 153.19 percentage points from the prior quarter.

Analysis

NewGenIvf (NIVF) EBIT Margin (2024 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, NewGenIvf reported EBIT Margin of -226.95%, down 205.59 percentage points from the prior year.

  • Annual EBIT Margin has declined for three straight years, with a four-year change of -231.77 percentage points (years ended Dec 2021 to Dec 2025).
  • Across earlier years, EBIT Margin came in at -21.36% in the year ended Dec 31, 2024 (-22.18 pp), 0.82% in the year ended Dec 31, 2023 (-5.89 pp), 6.71% in the year ended Dec 31, 2022 (+1.88 pp) and 4.83% in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 HCA Healthcare 94.08 Bn 93.52 Bn - 15.29%
2 Natera 59.53 Bn 55.21 Bn 485.19 Mn -10.07%
3 Quest Diagnostics 25.60 Bn 24.03 Bn 1.03 Bn 15.08%
4 Labcorp Holdings 24.98 Bn 22.75 Bn 1.11 Bn 12.10%
5 Guardant Health 23.75 Bn 19.81 Bn 219.03 Mn -38.55%
6 Tenet Healthcare 20.75 Bn 11.90 Bn - 26.67%
7 Tempus AI 14.47 Bn 11.50 Bn 246.50 Mn -19.85%
8 Encompass Health 12.19 Bn 12.65 Bn - 18.43%
9 Davita 11.20 Bn 9.97 Bn 1.16 Bn 16.29%
10 NewGenIvf 1,874.46 -4.69 Mn 524,025.00 -349.13%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -349.13%
Sep 30, 2025 -195.94%
Dec 31, 2024 -85.51%
Sep 30, 2024 14.69%
API Access

NewGenIvf EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=NIVF&period=max&api_key=YOUR_API_KEY